Mark Lawler, Associate Director of Postgraduate Studies and Chair in Translational Cancer Genomics at Queen’s University Belfast, shared post on LinkedIn:
“Looking forward to participating in this session at TCIGlobal25 in Dublin and highlighting the health dividend of peace, the economic dividend of health and the significant all-island opportunity to drive an oncology and digital health innovation agenda.”
More posts featuring Mark Lawler.